secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lexaria Bioscience Corp. (LEXX)
CIK:        0001348362
Form:       8-K
Filed at:   2026-08-17T16:37:43+00:00
Accession:  0001640334-26-001384
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Lexaria regains Nasdaq bid price compliance; hearing cancelled, stock remains listed
--------------------------------------------------------------------------------

- Received Nasdaq letter on Aug 17, 2026 confirming compliance with Rule 5550(a)(2) bid price requirement.
- Previously requested hearing before Nasdaq Hearings Advisor has been cancelled.
- Common stock (LEXX) continues trading on The Nasdaq Capital Market without interruption.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1348362/000164033426001384/0001640334-26-001384-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1348362/000164033426001384/lxrp_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-26-001384

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer